MedPath

JNJ-39758979

Generic Name
JNJ-39758979

A Study of the Safety and Effectiveness of JNJ-39758979 in the Treatment of Adults With Persistent Asthma

Phase 2
Completed
Conditions
Asthma
Interventions
Drug: Placebo
First Posted Date
2009-07-27
Last Posted Date
2014-04-29
Lead Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Target Recruit Count
116
Registration Number
NCT00946569
© Copyright 2025. All Rights Reserved by MedPath